• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery.CHA2DS2-VASc评分作为冠状动脉搭桥术后移植物失败的早期预测指标
Cureus. 2022 Mar 4;14(3):e22833. doi: 10.7759/cureus.22833. eCollection 2022 Mar.
2
Study on the predictive ability of emergency CHADS score and CHADS-VASc score for coronary artery disease and prognosis in patients with acute ST-segment elevation myocardial infarction.急诊CHADS评分和CHADS-VASc评分对急性ST段抬高型心肌梗死患者冠状动脉疾病及预后的预测能力研究
J Thorac Dis. 2022 Jul;14(7):2611-2620. doi: 10.21037/jtd-22-763.
3
Utility of the CHADS-VASc Score in Prediction of Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery.CHADS-VASc评分在冠状动脉旁路移植术后房颤预测中的应用
J Cardiothorac Vasc Anesth. 2022 May;36(5):1304-1309. doi: 10.1053/j.jvca.2021.07.028. Epub 2021 Jul 18.
4
CHADS2 and CHA2DS2-VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery.冠状动脉旁路移植术后即刻和晚期卒中的 CHADS2 和 CHA2DS2-VASc 评分。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1304-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.004. Epub 2012 Dec 14.
5
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
6
Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.CHA2DS2-VASc 评分对非心房颤动的非 ST 段抬高型心肌梗死患者高 SYNTAX 评分和住院死亡率的预测价值。
Anatol J Cardiol. 2021 Nov;25(11):789-795. doi: 10.5152/AnatolJCardiol.2021.03982.
7
CHA2DS2-Vasc score and saphenous vein graft disease in patients with coronary artery bypass graft surgery.CHA2DS2-Vasc 评分与冠状动脉旁路移植术患者的大隐静脉桥病变。
Coron Artery Dis. 2020 May;31(3):243-247. doi: 10.1097/MCA.0000000000000809.
8
CHADS-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator.CHADS-VASC评分可预测植入式心脏复律除颤器患者室性心律失常后的冠状动脉疾病进展和死亡率。
Int J Cardiol Heart Vasc. 2021 May 25;34:100802. doi: 10.1016/j.ijcha.2021.100802. eCollection 2021 Jun.
9
Use of CHA2DS2-VASc score to predict the risk of ischemic stroke and mortality in patients who underwent coronary artery bypass grafting surgery: a retrospective cohort study.应用 CHA2DS2-VASc 评分预测行冠状动脉旁路移植术患者的缺血性卒中风险和死亡率:一项回顾性队列研究。
Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):611-619. doi: 10.26355/eurrev_202301_31062.
10
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.

引用本文的文献

1
Development and validation of a machine learning-based model for perioperative stroke prediction in noncardiac, nonvascular, and nonneurosurgical patients.基于机器学习的非心脏、非血管和非神经外科手术患者围手术期卒中预测模型的开发与验证
Front Physiol. 2025 Jun 20;16:1624898. doi: 10.3389/fphys.2025.1624898. eCollection 2025.
2
CHA2DS2-VASc Score: What More Can it Predict?CHA2DS2-VASc评分:它还能预测什么?
Arq Bras Cardiol. 2023 Apr 7;120(4):e20220672. doi: 10.36660/abc.20220672.

本文引用的文献

1
Association between SYNTAX II Score and late saphenous vein graft failure in patients undergoing isolated coronary artery bypass graft surgery.SYNTAX II 评分与孤立性冠状动脉旁路移植术后大隐静脉桥晚期闭塞的关系。
Rev Assoc Med Bras (1992). 2021 Aug;67(8):1093-1101. doi: 10.1590/1806-9282.20210243.
2
CHA2DS2-Vasc score and saphenous vein graft disease in patients with coronary artery bypass graft surgery.CHA2DS2-Vasc 评分与冠状动脉旁路移植术患者的大隐静脉桥病变。
Coron Artery Dis. 2020 May;31(3):243-247. doi: 10.1097/MCA.0000000000000809.
3
Predictive Value of CHADS-VASc Score for Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention.CHADS-VASc评分对接受经皮冠状动脉介入治疗患者缺血事件的预测价值。
Angiology. 2019 Oct;70(9):878-886. doi: 10.1177/0003319718804661. Epub 2018 Oct 15.
4
Saphenous graft atherosclerosis as assessed by optical coherence tomography data for stenotic and non-stenotic lesions from the OCTOPUS registry.根据来自章鱼注册研究的光学相干断层扫描数据评估大隐静脉移植物动脉粥样硬化的狭窄和非狭窄病变。
Postepy Kardiol Interwencyjnej. 2018;14(2):157-166. doi: 10.5114/aic.2018.76407. Epub 2018 Jun 19.
5
Cardiovascular Risk Prediction in CKD.慢性肾脏病中的心血管风险预测。
Semin Nephrol. 2018 May;38(3):208-216. doi: 10.1016/j.semnephrol.2018.02.002.
6
The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis.机械二尖瓣血栓形成患者 CHA2DS2-VASc 评分的预测价值。
J Thromb Thrombolysis. 2018 May;45(4):571-577. doi: 10.1007/s11239-018-1640-3.
7
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.心力衰竭伴射血分数保留、轻度降低和中度降低:5 年结局。
J Am Coll Cardiol. 2017 Nov 14;70(20):2476-2486. doi: 10.1016/j.jacc.2017.08.074. Epub 2017 Nov 12.
8
Validation of the CHA2DS2-VASc Score in Predicting Coronary Atherosclerotic Burden and In-Hospital Mortality in Patients With Acute Coronary Syndrome.CHA2DS2-VASc评分在预测急性冠状动脉综合征患者冠状动脉粥样硬化负担及住院死亡率中的验证
Am J Cardiol. 2017 Jul 1;120(1):8-14. doi: 10.1016/j.amjcard.2017.03.266. Epub 2017 Apr 12.
9
CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome.急性冠状动脉综合征患者的CHA2DS2-VASc评分与临床结局
Eur J Intern Med. 2016 Dec;36:57-61. doi: 10.1016/j.ejim.2016.09.010. Epub 2016 Oct 1.
10
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.动脉粥样硬化的流行病学和减少全球动脉粥样血栓疾病负担的潜力。
Circ Res. 2016 Feb 19;118(4):535-46. doi: 10.1161/CIRCRESAHA.115.307611.

CHA2DS2-VASc评分作为冠状动脉搭桥术后移植物失败的早期预测指标

The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery.

作者信息

Tasbulak Omer, Sahin Anil

机构信息

Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, TUR.

出版信息

Cureus. 2022 Mar 4;14(3):e22833. doi: 10.7759/cureus.22833. eCollection 2022 Mar.

DOI:10.7759/cureus.22833
PMID:35382183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8976880/
Abstract

Background and objective Graft patency is one of the major concerns after coronary artery bypass graft (CABG) surgery. The CHADS-VASc [congestive heart failure, hypertension, age ≥75 years, diabetes mellitus (DM), stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category] score is a tool that was developed to predict the risk of thrombotic events in patients with atrial fibrillation (AF). In this study, we evaluated the use of the CHADS-VASc score as a simple tool for predicting graft failure (GF) among patients who underwent CABG surgery. Methods In this retrospective case-control study, a total of 280 patients were enrolled after applying the exclusion criteria. Angiograms were analyzed by using the QCA software system (Pie Medical Imaging, Maastricht, The Netherlands) for each patient. A graft was described as failed if it had 70% or more stenosis or was completely occluded. Patients were classified into two groups: group one included patients without GF (GF-N) and group two included patients with GF (GF-Y). Thereafter, the CHADS-VASc risk score was calculated for each patient. Results In our cohort, 136 patients had GF (GF-Y group) and 144 patients did not have GF (GF-N group). GF-N and GF-Y patients had their angiography performed 100.31 ± 8.04 and 103.49 ± 8.41 months after CABG, respectively. GF-Y group had a significantly higher rate of DM, hypertension, and heart failure with reduced ejection fraction (HFrEF). GF-Y group had higher CHADS(GF-N group: 1.47 ± 0.91 vs. GF-Y group: 2.57 ± 1.17, p=0.0001) and CHADS-VASc score (GF-N group: 2.80 ± 1.11 vs. GF-Y group: 4.15 ± 1.25, p=0.0001). Analyses showed that only CHADS-VASc was an independent predictor of GF while other parameters including DM, hypertension, HFrEF, creatinine, and CHADS were not found to be independent predictors of GF. A CHADS-VASc score of >3 predicted GF with a sensitivity of 65.44% and a specificity of 74.31%. Conclusions The CHADS-VASc score might be used as a feasible and simple method to predict the risk of GF after CABG surgery.

摘要

背景与目的 移植血管通畅是冠状动脉旁路移植术(CABG)后主要关注的问题之一。CHADS-VASc[充血性心力衰竭、高血压、年龄≥75岁、糖尿病(DM)、卒中或短暂性脑缺血发作(TIA)、血管疾病、年龄65至74岁、性别分类]评分是一种用于预测心房颤动(AF)患者血栓形成事件风险的工具。在本研究中,我们评估了CHADS-VASc评分作为预测接受CABG手术患者移植血管失败(GF)的一种简单工具的应用情况。方法 在这项回顾性病例对照研究中,应用排除标准后共纳入280例患者。使用QCA软件系统(荷兰马斯特里赫特的Pie Medical Imaging公司)对每位患者的血管造影进行分析。如果移植血管狭窄70%或以上或完全闭塞,则判定为失败。患者分为两组:第一组包括无GF的患者(GF-N组),第二组包括有GF的患者(GF-Y组)。此后,为每位患者计算CHADS-VASc风险评分。结果 在我们的队列中,136例患者有GF(GF-Y组),144例患者无GF(GF-N组)。GF-N组和GF-Y组患者分别在CABG术后100.31±8.04个月和103.49±8.41个月进行血管造影。GF-Y组的DM、高血压和射血分数降低的心力衰竭(HFrEF)发生率显著更高。GF-Y组的CHADS(GF-N组:1.47±0.91 vs. GF-Y组:2.57±1.17,p = 0.0001)和CHADS-VASc评分(GF-N组:2.80±1.11 vs. GF-Y组:4.15±1.25,p = 0.0001)更高。分析表明,只有CHADS-VASc是GF的独立预测因子,而包括DM、高血压、HFrEF、肌酐和CHADS在内的其他参数未被发现是GF的独立预测因子。CHADS-VASc评分>3预测GF的敏感性为65.44%,特异性为74.31%。结论 CHADS-VASc评分可能是预测CABG术后GF风险的一种可行且简单的方法。